SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Quantitative modeling of time to positivity following dosing of bedaquiline and rifafour in patients with pulmonary tuberculosis infection - J.F. MarierView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Drug Partitioning and Local Microenvironmental Conditions affect Bedaquiline, Clofazimine and Pyrazinamide Treatment Responses in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice - S. IrwinView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Prediction of drug partitioning into tubercular pulmonary lesions - C. ChenView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Digitizing MTB Medicines: Using compounding methods to enable mobile capture of MTB medication adherence - S. BrowneView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015TB and Diabetes Mellitus: Pharmacological Aspects of the Convergence of Two Epidemics - Rovina Ruslami, MD, PhDView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Mathematical model of drug-target binding predicts optimal antibiotic treatment - P. Abel zur WieschView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Dose optimization for combinations of three or more drugs: an application to dose selection in regimen-based tuberculosis drug development - M. LyonsView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 201512_WiltshireView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Concentration-response effects of combination therapy in a murine model of tuberculosis: optimizing the dosing regimen for short-course therapy - N. ZhangView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015The Systems Pharmacology Approach to Improve TB Treatment - Rada Savic, PharmD, PhDView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Pharmacokinetics of rifampicin and moxifloxacin in the PanACEA-MAMS-TB-01 trial - R. AarnoutseView Slideset
SlidesetInternational Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015Contribution of different oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in murine models of tuberculosis - R. TasneenView Slideset
